Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...

PRNewswire/ - NetraMark Holdings Inc. (the Company or NetraMark) (CSE: AIAI) (OTCQB: AINMF ) (Frankfurt: 8TV) </b ...

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

Alnylam Pharmaceuticals (ALNY) shares rallied 8.5% in the last trading session to close at $243.27. This move can be attributable to notable volume with a higher number of shares being traded than in ...

President Trump’s threatened tariffs could lead to higher out-of-pocket costs or insurance premiums, depending on whether ...

Using a non-GAAP industry average margin analysis of the short-run tariff impact, a 25% tariff would only amount to a ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

President Donald Trump said Wednesday he was open to providing company-specific tariff exemptions, noting the importance of being "flexible" in trade negotiations.

If you're worried about uncertainty and market volatility, consider these seven income-producing industrial REITs.

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.